SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,204,000 | -31.7% | 20,125 | -47.7% | 0.17% | -27.0% |
| Q1 2018 | $1,764,000 | -10.3% | 38,509 | -22.0% | 0.23% | -12.9% |
| Q4 2017 | $1,966,000 | +4.7% | 49,345 | +5.1% | 0.26% | -0.8% |
| Q3 2017 | $1,878,000 | -4.1% | 46,960 | +3.3% | 0.27% | -7.3% |
| Q2 2017 | $1,959,000 | +9.4% | 45,441 | -20.5% | 0.29% | +14.3% |
| Q1 2017 | $1,790,000 | +17.2% | 57,180 | -5.5% | 0.25% | +19.0% |
| Q4 2016 | $1,527,000 | +2.1% | 60,485 | 0.0% | 0.21% | -4.5% |
| Q3 2016 | $1,496,000 | +14.2% | 60,485 | -35.2% | 0.22% | +47.3% |
| Q3 2015 | $1,310,000 | – | 93,370 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |